ORGO  valuation analysis

Basics
Name: Organogenesis Holdings Inc
Description: Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. (more)
Industry: Drug Manufacturers-Specialty & Generic
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 10, 2022
Market cap: $759.65M (1292nd)
Sales(TTM): $463.62M (1261st)
Earnings(TTM): $85.05M (1033rd)

Value
FFER: 0.31*
Actual price: $5.72
* Earnings were reported Aug 08, 2022 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2022-05-25
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
Organogenesis Holdings Inc
"Drug Manufacturers-Specialty & Generic" industry
Sales / MarketCap
Organogenesis Holdings Inc
"Drug Manufacturers-Specialty & Generic" industry
Book / MarketCap
Organogenesis Holdings Inc
"Drug Manufacturers-Specialty & Generic" industry
Equity / Assets
Organogenesis Holdings Inc
"Drug Manufacturers-Specialty & Generic" industry